Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: Implications for ovarian cancer immunotherapy

British Journal of Cancer

Volumn 109, Issue 2, 2013, Pages 462-471

  Bellone, S ^a   Tassi, R ^b   Betti, M ^a   English, D ^a   Cocco, E ^a   Gasparrini, S ^a   Bortolomai, I ^a   Black, J D ^a   Todeschini, P ^b   Romani, C ^b   Ravaggi, A ^b   Bignotti, E ^b   Bandiera, E ^b   Zanotti, L ^b   Pecorelli, S ^b   Ardighieri, L ^b   Falchetti, M ^b   Donzelli, C ^b   Siegel, E R ^c   Azodi, M ^a   Silasi, D A ^a   Ratner, E ^a   Schwartz, P E ^a   Rutherford, T J ^a   Santin, A D ^a   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

CTL; cytotoxic T lymphocytes; dendritic cells; mammaglobin B (SCGB2A1); ovarian carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; HLA ANTIGEN; MAMMAGLOBIN B; RECOMBINANT MAMMAGLOBIN B; RNA; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CLEAR CELL CARCINOMA; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAINING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOTHERAPY; MAMMAGLOBIN B; MICROARRAY ANALYSIS; MIDDLE AGED; OVARIAN NEOPLASMS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; VALIDATION STUDIES AS TOPIC;

EID: 84881116105     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.315     Document Type: Article

References (25)

1. Aihara Y, Fujiwara M, Ooka I, Sakita Y, Tamaki, Monden M (1999) Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcriptionpolymerase chain reaction. Breast Cancer Res Treat 58: 137-140.
2. Becker RM, Darrow C, Zimonjic DB, Popescu NC, Watson MA, Fleming TP (1998) Identification of mammaglobin B, a novel member of uteroglobin gene family. Genomics 54: 70-78.
3. Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi D-A, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD (2009) Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1 positive healthy donors and patients with advanced ovarian cancer. Am J Obstet Gynecol 200: 75.e1-10.
4. Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi D-A, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD (2009) Generation of TADG-12-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1 positive healthy donors and patients with advanced ovarian cancer. Cancer 115: 800-811.
5. Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD (2006) Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 103: 405-416.
6. Cross SN, Cocco E, Bellone S, Anagnostou VK, Brower SL, Richter CE, Siegel ER, Schwartz PE, Rutherford TJ, Santin AD (2010) Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro. Am J Obstet Gynecol 203: 162.e1-8.
7. DiSaia PJ, Creasman WT eds. (2002) Epithelial Ovarian Cancer. Clinical Gynecologic Oncology. Mosby-Year Book, Inc.: St Louis 285-328.
8. Jackson BC, Thompson DC, Wright MW, McAndrews M, Bernard A, Nebert DW, Vasiliou V (2011) Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily. Hum Genomics 5: 691-702.
9. Jaramillo A, Narayanan K, Campbell LG, Benshoff ND, Lybarger L, Hansen TH, Fleming TP, Dietz JR, Mohanakumar T (2004) Recognition of HLAA2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat 88: 29-41.
10. Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age (2011) Nature 480: 480-489.
11. Mercatali L, Valenti V, Calistri D, Calpona S, Rosti G, Folli S (2006) RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients. Ann Oncol 17: 424-428.
12. Narayanan K, Jaramillo A, Benshoff ND, Campbell LG, Fleming TP, Dietz JR, Mohanakumar T (2004) Response of established human breast tumors to vaccination with mammaglobin-A cDNA. J Natl Cancer Inst 96: 1388-1396.
13. Nissan A, Jager D, Roystacher M (2006) Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer 94: 681-685.
14. O'Brien N, Maguire TM, O'Donovan N, Lynch N, Hill AD, McDermott E, O'Higgins N, Duffy MJ (2002) Mammaglobin a, a promising marker for breast cancer. Clin Chem 48: 1362-1364.
15. Ooka M, Sakita I, Fujiwara Y, Tamaki Y, Yamamoto H, Aihara T, Miyazaki M, Kadota M, Masuda N, Sugita Y, Iwao K, Monden M (2000) Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients. Oncol Rep 7: 561-566.
16. Romagnani S (1992) Human TH1 and TH2 subsets: Regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 98: 279-285.
17. Santin AD, Bellone S, Ravaggi A, Pecorelli S, Cannon MJ, Parham GP (2000) Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Obstet Gynecol 96: 422-430.
18. Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Jayaprabhu S, Pecorelli S, Parham GP, Cannon M (2001) Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. Clin Cancer Res 7(3 Suppl): 804s-810s.
19. Santin AD, Cané S, Bellone S, Palmieri M, Siegel ER, Thomas M, Roman JJ, Burnett A, Cannon MJ, Pecorelli S (2005) Treatment of chemotherapyresistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium Perfringens enterotoxin (CPE). Cancer Res 65: 4334-4342.
20. Seigel R, Naishadham D, Jemal A (2012) Cancer statistics-2012. CA Cancer J Clin 62: 10-29.
21. Tassi RA, Bignotti E, Rossi E, Falchetti M, Donzelli C, Calza S, Ravaggi A, Bandiera E, Pecorelli S, Santin AD (2007) Overexpression of mammaglobin B in epithelial ovarian carcinomas. Gynecol Oncol 105: 578-585.
22. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121.
23. Varughes J, Cocco E, Bellone S, Bellone M, Todeschini P, Carrara L, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD (2011) High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. Gynecol Oncol 122: 171-177.
24. Viehl CT, Tanaka Y, Chen T, Frey DM, Tran A, Fleming TP, Eberlein TJ, Goedegebuure PS (2005) Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells. Breast Cancer Res Treat 91: 271-278.
25. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 16: 203-213.